These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29245077)

  • 1. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
    Lund E; Nakamura A; Thalabard JC
    Eur J Cancer; 2018 Jan; 89():102-112. PubMed ID: 29245077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study.
    Lund E; Mode N; Waaseth M; Thalabard JC
    BMC Cancer; 2013 Dec; 13():614. PubMed ID: 24377727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer Study.
    Lund E; Nakamura A; Thalabard JC
    Eur J Cancer; 2018 Jul; 97():51-52. PubMed ID: 29759655
    [No Abstract]   [Full Text] [Related]  

  • 5. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
    Kalager M; Adami HO; Bretthauer M; Tamimi RM
    Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter comments on EJC published paper: 'No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study'.
    Zahl PH
    Eur J Cancer; 2018 Jul; 97():49-50. PubMed ID: 29759654
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
    Hofvind S; Skaane P
    Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands.
    Ripping TM; Verbeek AL; Fracheboud J; de Koning HJ; van Ravesteyn NT; Broeders MJ
    Int J Cancer; 2015 Aug; 137(4):921-9. PubMed ID: 25612892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
    van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
    Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of breast cancer before and after implementation of mammography screening].
    Hofvind S; Sørum R; Haldorsen T; Langmark F
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2935-8. PubMed ID: 17117191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
    Harding C; Pompei F; Burmistrov D; Wilson R
    Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program.
    Hofvind S; Román M; Sebuødegård S; Falk RS
    J Med Screen; 2016 Dec; 23(4):203-209. PubMed ID: 26940960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
    Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
    Michalopoulos D; Duffy SW
    J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?
    Hoff SR; Klepp O; Hofvind S
    J Med Screen; 2012 Dec; 19(4):177-83. PubMed ID: 23486698
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.